Form 4: Kura Oncology CEO Buys Shares
Insider Transaction (Form 4)
Troy Edward Wilson, President and CEO and a Director of Kura Oncology, Inc., purchased 100,000 shares of common stock on August 17, 2026 for $11.12 per share.
Summary
- Open-market purchase: acquired 100,000 Common Stock at $11.12 ($1,112,000) on August 17, 2026; holds 379,194 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $1,112,000, committing personal capital to the stock.
Insider Transactions
Troy Edward Wilson — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Open-market purchase | Common Stock | 100,000 | $11 | $1.1M | 379,194 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Open-market purchase (100,000 shares) |
Keywords
insider transaction, Form 4, KURA, Kura Oncology, Inc., bullish, Troy Edward Wilson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.